Form 8-K INTERCEPT PHARMACEUTICAL For: Mar 08

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. GMAB
4. ACCV
5. FLG
6. META
7. FICO
8. SMMT
9. QQQ
10. SPCX

Go back to Form 8-K INTERCEPT PHARMACEUTICAL For: Mar 08

H.C. Wainwright Upgrades Intercept Pharmaceuticals (ICPT) to Neutral

March 12, 2021 6:15 AM EST

H.C. Wainwright analyst Ed Arce upgraded Intercept Pharmaceuticals (NASDAQ: ICPT) from Sell to Neutral with a price target of $21.00 (from $25.00).

The analyst comments "We downgraded ICPT to Sell on February 23 when it traded at about $30 per share (prior close $29.86). The shares hit a multi-year low of $19.33 on March 4, and are now close to $21, largely on recent macroeconomic optimism, in our view. Our underlying thesis (NASH program has little to no risk-adjusted value, and PBC franchise faces substantial risks) has not changed. However, given the drop in... More